When does this change take effect?

This change is effective Dec 19, 2025.

CommercialCoverageMedium impact

06.02.37a, Immune Cell Function Assay

Q: Who is affected by this change?

This affects Independence Blue Cross Allergy & Immunology, Oncology, Hematology, Rheumatology providers on Commercial plans.

Independence Blue Cross·Allergy & Immunology, Oncology, Hematology +1 more·Medical Policy

Effective date

Dec 19, 2025

We identified it

Jun 19, 2026

Days to comply

—

Summary

The Immune Cell Function Assay policy (06.02.37a) has been reissued with an effective date of December 19, 2025. This is a commercial plan policy update, but specific details about what changed are not provided in the summary.

Action Required

Action needed

By December 19, 2025: Billing team should access the full policy at the provided URL to review specific changes to immune cell function assay coverage and billing requirements. Update billing procedures and prior authorization requirements as specified in the complete policy document.

Related policy hubs

Independence Blue Cross policies Allergy & Immunology Oncology Hematology Rheumatology